BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia ; volume:38 ; number:1 ; day:9 ; month:11 ; year:2023 ; pages:136-148 ; date:1.2024
Leukemia ; 38, Heft 1 (9.11.2023), 136-148, 1.2024
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-023-02079-5
- URN
-
urn:nbn:de:101:1-2024032122122665888963
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wu, Ying
- Zehnle, Patricia M. A.
- Rajak, Jovana
- Koleci, Naile
- Geoffroy, Andrieux
- Gallego-Villar, Lorena
- Aumann, Konrad
- Börries, Melanie
- Niemeyer, Charlotte
- Flotho, Christian
- Bohler, Sheila
- Erlacher, Miriam
- SpringerLink (Online service)
Other Objects (12)
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
Current treatment of juvenile myelomonocytic leukemia
Characterization of pro- and anti-apoptotic BCL-2 proteins regulating leukemogenesis in juvenile myelomonocytic leukemia (JMML)
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: genetic evidence of driver function and implications for diagnostic workup
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
Assessment of a novel NRAS in-frame tandem duplication causing a myelodysplastic/myeloproliferative neoplasm
Missing cells: pathophysiology, diagnosis, and management of (pan)cytopenia in childhood
Sickle cell disease in Germany: results from a national registry
The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
Current treatment of juvenile myelomonocytic leukemia
Characterization of pro- and anti-apoptotic BCL-2 proteins regulating leukemogenesis in juvenile myelomonocytic leukemia (JMML)
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: genetic evidence of driver function and implications for diagnostic workup
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
Assessment of a novel NRAS in-frame tandem duplication causing a myelodysplastic/myeloproliferative neoplasm
Missing cells: pathophysiology, diagnosis, and management of (pan)cytopenia in childhood
Sickle cell disease in Germany: results from a national registry
The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
Current treatment of juvenile myelomonocytic leukemia
Characterization of pro- and anti-apoptotic BCL-2 proteins regulating leukemogenesis in juvenile myelomonocytic leukemia (JMML)
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: genetic evidence of driver function and implications for diagnostic workup
Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
Assessment of a novel NRAS in-frame tandem duplication causing a myelodysplastic/myeloproliferative neoplasm
Missing cells: pathophysiology, diagnosis, and management of (pan)cytopenia in childhood
Sickle cell disease in Germany: results from a national registry